(Q28217624)

English

Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers

scientific article (publication date: 2005)

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

H Caplain

1

0 references

language of work or name

0 references

publication date

2005

0 references

Cerebrovascular Diseases

0 references

19

0 references

4

0 references

214-9

0 references

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

Near-field amplification of antithrombotic effects of dipyridamole through vessel wall cells

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

Aspirin improves endothelial dysfunction in atherosclerosis

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

Effects of ADP-receptor antagonism beyond traditional inhibition of platelet aggregation

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

COMBINING ANTIPLATELET AGENTS: POTENTIATION BETWEEN ASPIRIN AND DIPYRIDAMOLE

1 reference

https://api.crossref.org/works/10.1159%2F000083885

21 January 2018

Identifiers

10.1159/000083885

0 references

release_bwhuwu6ncjea5byfp3fszdqr2i

1 reference

https://api.fatcat.wiki/v0/release/bwhuwu6ncjea5byfp3fszdqr2i

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28217624&oldid=1844547164"